Logo
  • Home
  • AI Agent
  • Annotations
  • Watchlists
  • Files
  • Pricing and plans
  • BlogAboutContact us
    APIMCP
    Terms of servicePrivacy policy

  • Get the full experience

    We save the real magic for signed-in users.

Logo
PVCT US​

Provectus Biopharmaceuticals, Inc. Class A(PVCT US)

$0.05-0.004.00%Ext:$0.05-0.000.63%(Market Closed · 20:00:00 UTC)

Overview

ProfileEntity Structure

Documents

SEC Filings
CategorizedChronologicalBy Owner

SEC Filings

Financials(134)

Expand
  • 10-QQ2ended 30 Jun 202613 Aug
  • 10-QQ1ended 31 Mar 202614 May
  • 10-KFY 2025ended 31 Dec 202525 Mar
  • 10-QQ3ended 30 Sept 202513 Nov 2025
  • 10-QQ2ended 30 Jun 202514 Aug 2025
  • 10-K/AFY 2024ended 31 Dec 202416 May 2025
  • 10-QQ1ended 31 Mar 202514 May 2025
  • 10-KFY 2024ended 31 Dec 202428 Mar 2025
  • 10-QQ3ended 30 Sept 202412 Nov 2024
  • 10-QQ2ended 30 Jun 202413 Aug 2024
  • 10-QQ1ended 31 Mar 202414 May 2024
  • 10-K/AFY 2023ended 31 Dec 202329 Apr 2024
  • 10-KFY 2023ended 31 Dec 202328 Mar 2024
  • 10-QQ3ended 30 Sept 202314 Nov 2023
  • 10-QQ2ended 30 Jun 202314 Aug 2023

Events(296)

Expand
  • 8-KDeparture of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers30 Jun
  • 8-KSubmission of Matters to a Vote of Security Holders22 Jun
  • 8-KRegulation FD Disclosure18 Jun
  • 8-KOther Events20 Apr
  • 8-KAmendments to Articles of Incorporation or Bylaws; Change in Fiscal Year2 Feb
  • 8-KSubmission of Matters to Shareholder Vote20 Jun 2025
  • 8-KRegulation FD Disclosure18 Jun 2025
  • 8-KChange in Certifying Accountant16 Apr 2025
  • 8-KEntry into Material Agreement22 Jan 2025
  • 8-KEntry into Material Agreement26 Dec 2024
  • 8-KOther Events11 Dec 2024
  • 8-KDirector/Officer Changes & Compensatory Arrangements5 Dec 2024
  • 8-KRegulation FD Disclosure14 Nov 2024
  • 8-KDirector/Officer Changes & Compensatory Arrangements19 Aug 2024
  • 8-KEntry into Material Agreement17 Jul 2024

Insider Ownership(364)

Expand
  • 4Statement of changes in beneficial ownership23 Oct
  • 4Statement of changes in beneficial ownership13 Oct
  • 4Statement of changes in beneficial ownership5 Oct
  • 4Statement of changes in beneficial ownership18 Sep
  • 4Statement of changes in beneficial ownership11 Sep
  • 4Statement of changes in beneficial ownership8 Sep
  • 4Statement of changes in beneficial ownership26 Aug
  • 4Statement of changes in beneficial ownership2 Jul
  • 4Statement of changes in beneficial ownership30 Jun
  • 4Statement of changes in beneficial ownership30 Jun
  • 4Statement of changes in beneficial ownership30 Jun
  • 4Statement of changes in beneficial ownership5 Jun
  • 4Statement of changes in beneficial ownership29 May
  • 4Statement of changes in beneficial ownership26 May
  • 4Statement of changes in beneficial ownership15 May

Beneficial Ownership(30)

Expand
  • SC 13D/APROVECTUS BIOPHARMACEUTICALS, INC.22 Jul
  • SC 13DPROVECTUS BIOPHARMACEUTICALS, INC.8 Dec 2025
  • SC 13D/APROVECTUS BIOPHARMACEUTICALS, INC.1 Dec 2025
  • SC 13D/APROVECTUS BIOPHARMACEUTICALS, INC.6 Dec 2024
  • SC 13GPROVECTUS BIOPHARMACEUTICALS, INC.14 Aug 2024
  • SC 13DPROVECTUS BIOPHARMACEUTICALS, INC.3 Jul 2024
  • SC 13GPROVECTUS BIOPHARMACEUTICALS, INC.9 May 2023
  • SC 13GPROVECTUS BIOPHARMACEUTICALS, INC.28 Mar 2023
  • SC 13DPROVECTUS BIOPHARMACEUTICALS, INC.30 Jun 2021
  • SC 13D/APROVECTUS BIOPHARMACEUTICALS, INC.17 Apr 2017
  • SC 13DPROVECTUS BIOPHARMACEUTICALS, INC.30 Mar 2017
  • SC 13D/APROVECTUS BIOPHARMACEUTICALS, INC.30 Mar 2017
  • SC 13D/APROVECTUS BIOPHARMACEUTICALS, INC.21 Mar 2017
  • SC 13D/APROVECTUS BIOPHARMACEUTICALS, INC.27 Jan 2017
  • SC 13DPROVECTUS BIOPHARMACEUTICALS, INC.5 Jan 2017

Proxies(74)

Expand
  • ARSAnnual report to security holders30 Apr
  • DEFA14ADefinitive additional materials30 Apr
  • DEF 14ADefinitive proxy statement30 Apr
  • PRE 14APreliminary proxy statement20 Apr
  • DEFA14ADefinitive additional materials18 Jun 2025
  • ARSAnnual report to security holders5 May 2025
  • DEF 14ADefinitive proxy statement1 May 2025
  • DEFA14ADefinitive additional materials1 May 2025
  • PRE 14APreliminary proxy statement18 Apr 2025
  • DEFA14ADefinitive additional materials20 Jun 2024
  • ARSAnnual report to security holders9 May 2024
  • DEF 14ADefinitive proxy statement6 May 2024
  • DEFA14ADefinitive additional materials6 May 2024
  • PRE 14APreliminary proxy statement26 Apr 2024
  • DEFA14ADefinitive additional materials21 Jun 2023

Registrations(72)

Expand
  • 25-NSENotification of removal from listing21 Apr 2017
  • 25-NSENotification of removal from listing21 Apr 2017
  • 424B3Prospectus filing (Rule 424(b)(3))6 Mar 2017
  • 424B3Prospectus filing (Rule 424(b)(3))21 Feb 2017
  • 424B3Prospectus filing (Rule 424(b)(3))9 Feb 2017
  • 424B4FORM 424(B)(4)31 Jan 2017
  • S-1/ARegistration statement (general form, amendment)26 Jan 2017
  • S-1/AAMENDMENT NO. 5 TO FORM S-119 Jan 2017
  • S-1/ARegistration statement (general form, amendment)21 Dec 2016
  • S-1/ARegistration statement (general form, amendment)6 Dec 2016
  • S-1/ARegistration statement (general form, amendment)22 Nov 2016
  • S-1/ARegistration statement (general form, amendment)1 Nov 2016
  • S-1Registration statement (general form)5 Oct 2016
  • 424B5Prospectus filing (Rule 424(b)(5))26 Aug 2016
  • 424B5Prospectus filing (Rule 424(b)(5))24 Aug 2016

Filing Review Correspondence(9)

Expand
  • CORRESPFiling review correspondence27 Jan 2017
  • CORRESPFiling review correspondence25 Jan 2017
  • CORRESPFiling review correspondence19 Dec 2016
  • CORRESPFiling review correspondence22 Nov 2016
  • CORRESPFiling review correspondence1 Nov 2016
  • CORRESPFiling review correspondence20 Oct 2016
  • CORRESPFiling review correspondence25 May 2016
  • CORRESPFiling review correspondence13 Jan 2016
  • CORRESPFiling review correspondence23 Jul 2015

SEC Orders And Notices(17)

Expand
  • EFFECTNotice of effectiveness27 Jan 2017
  • EFFECTNotice of effectiveness27 May 2016
  • EFFECTNotice of effectiveness11 May 2016
  • EFFECTNotice of effectiveness15 Jan 2016
  • EFFECTNotice of effectiveness27 Jul 2015
  • CT ORDERConfidential treatment order8 Jul 2014
  • EFFECTNotice of effectiveness15 Apr 2013
  • EFFECTNotice of effectiveness9 Apr 2013
  • EFFECTNotice of effectiveness9 Apr 2013
  • EFFECTNotice of effectiveness20 Jul 2012
  • EFFECTNotice of effectiveness5 Aug 2011
  • EFFECTNotice of effectiveness5 Aug 2010
  • EFFECTNotice of effectiveness14 Jul 2010
  • CT ORDERConfidential treatment order15 Jan 2010
  • EFFECTNotice of effectiveness11 Jun 2009

Tender Offers And Going Private(8)

Expand
  • SC TO-I/ATender offer statement (issuer, amendment)28 Jul 2016
  • SC TO-I/ATender offer statement (issuer, amendment)28 Jun 2016
  • SC TO-ITender offer statement (issuer)13 May 2016
  • SC TO-I/ATender offer statement (issuer, amendment)31 Mar 2016
  • SC TO-I/ATender offer statement (issuer, amendment)22 Mar 2016
  • SC TO-I/ATender offer statement (issuer, amendment)7 Mar 2016
  • SC TO-I/ATender offer statement (issuer, amendment)12 Feb 2016
  • SC TO-ITender offer statement (issuer)31 Dec 2015

Exempt Offerings(17)

Expand
  • D06b17 Jul 2024
  • D06b28 Oct 2022
  • D<ITEMS>06b30 Aug 2021
  • D06b15 Oct 2014
  • D06b17 Apr 2014
  • D06b26 Sep 2013
  • DNotice of exempt offering of securities (Reg D)8 Mar 2013
  • DNotice of exempt offering of securities (Reg D)19 Nov 2012
  • DNotice of exempt offering of securities (Reg D)3 Aug 2012
  • DNotice of exempt offering of securities (Reg D)22 Mar 2012
  • DNotice of exempt offering of securities (Reg D)5 May 2011
  • DNotice of exempt offering of securities (Reg D)13 May 2010
  • DNotice of exempt offering of securities (Reg D)6 Apr 2010
  • D/ANotice of exempt offering of securities (Reg D, amendment)26 Mar 2010
  • DNotice of exempt offering of securities (Reg D)24 Mar 2010

Other(14)

Expand
  • CERTNYSAUTO-GENERATED PAPER DOCUMENT19 Jun 2015
  • CERTNYSAUTO-GENERATED PAPER DOCUMENT14 May 2014
  • SB-2/APVCT SB2A2 01-24-0828 Jan 2008
  • SB-2/APVCT SB2/A 01-04-087 Jan 2008
  • SB-2PVCT SB2 11-30-073 Dec 2007
  • SB-2/APVCT SB2/A 05-0624 May 2006
  • SB-2PVCT SB2 05-0611 May 2006
  • S-2/AAMENDMENT NO. 114 Jun 2005
  • S-2REGISTRATION STATEMENT16 May 2005
  • S-2/AS-2/A10 Nov 2004
  • S-2/AS-2/A5 Nov 2004
  • S-2REGISTRATION STATEMENT7 Oct 2004
  • S-2/AREGISTRATION ON FORM S-2 AMENDED7 Apr 2004
  • S-2S-212 Feb 2004

Financials & Metrics

FinancialsChartingShort InterestEmployees